RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
ACRO Biomedical Co Stock

ACRO Biomedical Co EBIT 2024

ACRO Biomedical Co EBIT

-15.87 M USD

Ticker

ACBM

ISIN

US0048921052

In 2024, ACRO Biomedical Co's EBIT was -15.87 M USD, a 106.37% increase from the -7.69 M USD EBIT recorded in the previous year.

The ACRO Biomedical Co EBIT history

YEAREBIT (undefined USD)
2022-15,870
2021-7,690
2020-130
2019-440
2018520
2017-
2016-40
2015-50
2014-
2013-

ACRO Biomedical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into ACRO Biomedical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by ACRO Biomedical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects ACRO Biomedical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of ACRO Biomedical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into ACRO Biomedical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing ACRO Biomedical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on ACRO Biomedical Co’s growth potential.

ACRO Biomedical Co Revenue, EBIT and net profit per share

DateACRO Biomedical Co RevenueACRO Biomedical Co EBITACRO Biomedical Co Net Income
2022660,000 undefined-15.87 M undefined-15.87 M undefined
20211.2 M undefined-7.69 M undefined-7.7 M undefined
2020690,000 undefined-130,000 undefined-120,000 undefined
20191.35 M undefined-440,000 undefined-370,000 undefined
20188.01 M undefined520,000 undefined420,000 undefined
2017510,000 undefined0 undefined0 undefined
20160 undefined-40,000 undefined-40,000 undefined
20150 undefined-50,000 undefined-50,000 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined

ACRO Biomedical Co stock margins

The ACRO Biomedical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of ACRO Biomedical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for ACRO Biomedical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the ACRO Biomedical Co's sales revenue. A higher gross margin percentage indicates that the ACRO Biomedical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the ACRO Biomedical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the ACRO Biomedical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the ACRO Biomedical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the ACRO Biomedical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the ACRO Biomedical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

ACRO Biomedical Co Margin History

ACRO Biomedical Co Gross marginACRO Biomedical Co Profit marginACRO Biomedical Co EBIT marginACRO Biomedical Co Profit margin
202221.21 %-2,404.55 %-2,404.55 %
202121.67 %-640.83 %-641.67 %
202023.19 %-18.84 %-17.39 %
201910.37 %-32.59 %-27.41 %
201810.36 %6.49 %5.24 %
20179.8 %0 %0 %
201621.21 %0 %0 %
201521.21 %0 %0 %
201421.21 %0 %0 %
201321.21 %0 %0 %

ACRO Biomedical Co Aktienanalyse

What does ACRO Biomedical Co do?

ACRO Biomedical Co Ltd is a leading company in biomedical technology based in Taipei, Taiwan. The company was established in 2006 and has since successfully established itself in the global market for biomedical products and technologies. The company's vision is to improve people's lives and promote health worldwide through innovative and high-quality products and solutions. Business model: ACRO Biomedical Co Ltd specializes in the development, manufacturing, and marketing of biomedical products and technologies. The company has three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology. Each division focuses on developing products and solutions tailored to the needs of patients and medical professionals. Regenerative Medicine: ACRO Biomedical Co Ltd is a leading provider of regenerative biomedical products. Under this division, the company develops innovative solutions for tissue regeneration, such as bioimplants made from natural tissues and biomaterials to repair or restore damaged tissue. These products are used for the treatment of injuries, chronic diseases, and degenerative conditions. Additionally, ACRO Biomedical Co Ltd has also developed solutions for cosmetic and aesthetic applications. Wound Care: ACRO Biomedical Co Ltd's wound care division specializes in developing products and solutions that help accelerate wound healing, prevent infections, and reduce the risk of complications. The company offers a wide range of products, including antimicrobial and moist wound dressings, which are used for the treatment of acute and chronic wounds such as burns, abrasions, and diabetic foot ulcers. Surgical Technology: ACRO Biomedical Co Ltd's surgical technology division provides healthcare professionals with a wide range of surgical products for various applications, including neurosurgery, plastic surgery, and general surgery. The innovative products offered by ACRO Biomedical Co Ltd for surgical applications include cutting tools, implants, and instruments for minimally invasive procedures. Products: ACRO Biomedical Co Ltd offers a wide range of products for various applications and medical specialties. Some of the company's key products include: - ACL-Bioimplant: A bioimplant for cruciate ligament repair made from human cartilage and biomaterials. - ACRO-CAF: A bone grafting material for bone transplantation. - ACRO-Mixtop: A wound healing agent for the treatment of burns, abrasions, and chronic wounds. - ACRO-OSTEOT: A surgical bone drill for orthopedics and neurosurgery. - ACRO-BioSIS: A tissue adhesive for surgical applications. Summary: ACRO Biomedical Co Ltd is a leading company in biomedical technology that offers innovative solutions for the preservation and restoration of people's health. With its three main divisions: Regenerative Medicine, Wound Care, and Surgical Technology, the company provides a wide range of products and solutions for medical professionals and patients. The company's products are marketed worldwide and are known for their quality, reliability, and effectiveness. ACRO Biomedical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing ACRO Biomedical Co's EBIT

ACRO Biomedical Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of ACRO Biomedical Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

ACRO Biomedical Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in ACRO Biomedical Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about ACRO Biomedical Co stock

How much did ACRO Biomedical Co achieve in EBIT for the current year?

In the current year, ACRO Biomedical Co has achieved an EBIT of -15.87 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company ACRO Biomedical Co.

How has the EBIT of ACRO Biomedical Co developed in recent years?

The EBIT of ACRO Biomedical Co has increased by 106.372% increased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company ACRO Biomedical Co?

The EBIT of ACRO Biomedical Co is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does ACRO Biomedical Co pay?

Over the past 12 months, ACRO Biomedical Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, ACRO Biomedical Co is expected to pay a dividend of 0 USD.

What is the dividend yield of ACRO Biomedical Co?

The current dividend yield of ACRO Biomedical Co is .

When does ACRO Biomedical Co pay dividends?

ACRO Biomedical Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of ACRO Biomedical Co?

ACRO Biomedical Co paid dividends every year for the past 0 years.

What is the dividend of ACRO Biomedical Co?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is ACRO Biomedical Co located?

ACRO Biomedical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von ACRO Biomedical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of ACRO Biomedical Co from 11/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/3/2024.

When did ACRO Biomedical Co pay the last dividend?

The last dividend was paid out on 11/3/2024.

What was the dividend of ACRO Biomedical Co in the year 2023?

In the year 2023, ACRO Biomedical Co distributed 0 USD as dividends.

In which currency does ACRO Biomedical Co pay out the dividend?

The dividends of ACRO Biomedical Co are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von ACRO Biomedical Co

Our stock analysis for ACRO Biomedical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ACRO Biomedical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.